Skip to main content
NewslettersWatchlist

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Newswire.ca - Thu Apr 11, 6:00AM CDT

Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metastatic breast cancer

Overall survival results from the randomized HR+/HER2- metastatic breast cancer BRACELET-1 trial expected in H2 2024

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

market news
Premarket: Stocks rally as investors eye interest rate moves
NEW YORK, NEW YORK - MAY 31: Traders work on the floor of the New York Stock Exchange during morning trading on May 31, 2024 in New York City. Stocks rose at the opening of the stock market after the release of the Personal Consumption Expenditures price index which showed that inflation rose 0.2% in April. (Photo by Michael M. Santiago/Getty Images)
inside the market
Before the Bell: What every Canadian investor needs to know today
NEW YORK, NEW YORK - MAY 31: Traders work on the floor of the New York Stock Exchange during morning trading on May 31, 2024 in New York City. Stocks rose at the opening of the stock market after the release of the Personal Consumption Expenditures price index which showed that inflation rose 0.2% in April. (Photo by Michael M. Santiago/Getty Images)
globe investor
GameStop soars 90% after super bull Roaring Kitty’s Reddit post shows US$116-million bet
A screen displays the logo and trading information for GameStop on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2022.
inside the market
Bargain prices for stable dividend stocks
Norman Rothery
market news
The close: Month-end repositioning spurs late-day stock rally
Trader Anthony Confusione works on the floor of the New York Stock Exchange, Thursday, May 30.
alternative investments
Fund houses buy up ‘alts’ specialists to move beyond equities and bonds
FILE PHOTO: Larry Fink, Chief Executive Officer of BlackRock, takes part in the Yahoo Finance All Markets Summit in New York, U.S., February 8, 2017. REUTERS/Lucas Jackson
opinion
Four reasons why wealthy investors should hold farmland in their portfolios
Andrea Gruza
alternative investments
Four ways to create more diversified and resilient portfolios
One of a set. Graphic Arrow on abstract background.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).